Clinical Trial Update: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 safety study of TRx0237 in Alzheimer's disease patients already taking other Alzheimer's medications was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TRx0237

Snippet

Sponsor: TauRx Therapeutics Ltd | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED | Results posted: 2014-07-11